化合物RIPA-56 T7795
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 1956370-21-0 | ¥2,170.00 | 询底价 |
200 mg | 1956370-21-0 | ¥3,870.00 | 询底价 |
25 mg | 1956370-21-0 | ¥816.00 | 询底价 |
1 mL | 1956370-21-0 | ¥416.00 | 询底价 |
50 mg | 1956370-21-0 | ¥1,370.00 | 询底价 |
10 mg | 1956370-21-0 | ¥455.00 | 询底价 |
5 mg | 1956370-21-0 | ¥281.00 | 询底价 |
500 mg | 1956370-21-0 | ¥6,130.00 | 询底价 |
Product Introduction
Bioactivity
英文名: RIPA-56
描述: RIPA-56 是一种高效选择和代谢稳定的受体相互作用蛋白 1 抑制剂,可研究全身炎症反应综合征,IC50为 13 nM。
体内活性: In the SIRS mice disease model, RIPA-56?efficiently reduced tumor necrosis factor alpha (TNFα)-induced mortality and multi-organ damage.?Compared to known RIP1 inhibitors, RIPA-56?is potent in both human and murine cells, is much more stable in vivo, and is efficacious in animal model?studies.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 100 mg/mL (451.88 mM)
关键字: inhibit | Receptor-interacting protein kinases | RIPA-56 | RIPA 56 | RIP kinase | RIPK | RIPA56 | Inhibitor
相关产品: GSK872 HCl(1346546-69-7 free base) | RIP2 Kinase Inhibitor 3 | HTH-01-091 | RI-962 | GSK-843 | Necrostatin-1 | Eclitasertib | RIPK3-IN-4 | GSK3145095 | GSK481
相关库: Anti-Prostate Cancer Compound Library | Anti-Liver Cancer Compound Library | Pyroptosis Compound Library | Anti-Cancer Compound Library | NF-κB Signaling Compound Library | Antidepressant Compound Library | Anti-Ovarian Cancer Compound Library | Kinase Inhibitor Library | Inhibitor Library | NO PAINS Compound Library
化合物RIPA-56 T7795信息由TargetMol中国为您提供,如您想了解更多关于化合物RIPA-56 T7795报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途